[1]CurrentPatentAssignee:OTSUKAHOLDINGSCOLTD-US2018/354930,2018,A1Locationinpatent:Paragraph0128
141635-93-0 | 4,6,7,8-Tetrahydro-8-hydroxy-6-methylpyrimido[1,2-a]purin-10(3H)-one (Mixture of Diastereomers) | AA009F0F | MFCD28898487
122331-70-8 | Ethyl 2-Acetamido-2-deoxy-β-D-thioglucopyranoside | AA009F68 | MFCD18643045
125833-03-6 | RIFAMPICIN N-OXIDE | AA009FEP
1216989-17-1 | D 13223-d4 (Flupirtine Metabolite) | AA009FMI | MFCD19704993
124001-41-8 | ICI 216,140 | AA009FWX | MFCD00153815
142733-63-9 | Methyl cis-3-(Boc-amino)cyclobutanecarboxylate | AA009GIL | MFCD20922913
13372-77-5 | 3,7-dimethylocta-2,6-dienal oxime | AA009GVU | MFCD00072196
143361-87-9 | 3-Benzothiazol-2-yl-4,5,6,7-tetrahydro-benzo[b]thiophen-2-ylamine | AA009HTK | MFCD02360332
1213693-68-5 | (S)-Cyclopropyl(4-methoxyphenyl)methanamine hydrochloride | AA009IBT | MFCD11101160
1313727-03-5 | PYRAZOLO[1,5-A]PYRIDIN-5-YLMETHANAMINE(STRID308183532) | AA009IWA | MFCD22396357